9 months ago

The global brachytherapy market is projected to be worth USD 548.8 Million by 2027, according to a current analysis by Emergen Research. The brachytherapy market is experiencing an increased demand attributed to its growing application in the treatment of cancer. Cancer has a significant impact on global society. According to the statistics published by the National Cancer Institute, about 1,806,590 new cancer cases will be diagnosed in the US in 2020 and will account for the death of 606,520 individuals. In 2020, prostate, colorectal, and lung cancers will be responsible for a projected 43.0% diagnosed cases in men. On the other hand, breast, colorectal, and lung cancer are the most common causes of cancer in women and will be responsible for a projected 50.0% of diagnosed cases.

The latest report is the first study encompassing the current Brachytherapy market situation with respect to the COVID-19 outbreak. Since the advent of the outbreak, the global economic landscape has been grappling with adverse financial consequences. The report analyzes the drastic impact of the pandemic on this business sphere. The pandemic has affected nearly all segments of the Brachytherapy market. It has further hampered the developmental scope of various manufacturers and buyers engaged in this sector. Thus, the report studies the industry’s shifting dynamics to scrutinize the profits earned or loss suffered by different segments.

For more details of the Brachytherapy Market Report, visit @ https://www.emergenresearch.com/industry-report/brachytherapy-market